SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-052697
Filing Date
2022-04-29
Accepted
2022-04-29 06:05:34
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm223510d2_defa14a.htm DEFA14A 15398
2 GRAPHIC tm223510d2_defa14aimg001.jpg GRAPHIC 181879
3 GRAPHIC tm223510d2_defa14aimg002.jpg GRAPHIC 114373
  Complete submission text file 0001104659-22-052697.txt   424668
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38650 | Film No.: 22869835
SIC: 2834 Pharmaceutical Preparations